EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MicroRNA-451 as an Early Predictor of Chronic Kidney Disease in Diabetic Nephropathy

Mostafa Abdelsalam, A M Wahab, Maysaa El Sayed Zaki, Mohamad Motawea iD

International Journal of Nephrology · 14.08.2020 · 2020 · 1-7

DOI: 10.1155/2020/8075376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nephrology, erschienen am 14.08.2020. Verfasst von Mostafa Abdelsalam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mansoura Nephrology and Dialysis Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetes mellitus is the leading cause of end-stage renal disease worldwide. Microalbuminuria is the cornerstone for the diagnosis of diabetic nephropathy. However, it is an inadequate marker for early diagnosis. MicroRNAs are not only new and promising markers for early diagnosis but also, but they may also play a role in the prevention of disease progression.

Methods

This study included ninety patients with type 2 DM in addition to 30 control subjects. MicroRNA-451 expression in blood and plasma using real-time PCR was evaluated in addition to the classic diabetic nephropathy markers (serum creatinine, urinary albumin, and eGFR).

Results

There was a significant difference between the studied groups versus control regarding serum creatinine, eGFR, urinary, and plasma microRNA-451 with p = 0.0001 . Patients with eGFR 60 ml/min/1.73 m 2 showed a significantly higher plasma microRNA-451 (29.6 ± 1.6) and significantly lower urinary microRNA-451 (21 ± 0.9) in comparison to patients with eGFR >60 ml/min/1.73 m 2 and p = 0.0001 . eGFR showed a positive correlation with urinary microRNA-451 and negative correlation with both plasma microRNA-451 and urinary albumin. Both plasma and urinary microRNA-451 are highly sensitive and specific markers for chronicity in diabetic nephropathy patients with sensitivity of 90.9% and 95.5% and specificity of 67.6% and 95.6%, respectively.

Conclusion

MicroRNA-451 is a promising early biomarker for chronic kidney disease in diabetic nephropathy with high sensitivity and specificity.

Autor:innen und Institutionen

  • Mansoura Nephrology and Dialysis Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  • Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  • Endocrinology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

ORCID-Profile: Mohamad Motawea

Zitieren

APA

Abdelsalam, M., Wahab, A. M., El Sayed Zaki, M., & Motawea, M. (2020). MicroRNA-451 as an Early Predictor of Chronic Kidney Disease in Diabetic Nephropathy. International Journal of Nephrology, 2020, 1-7. https://doi.org/10.1155/2020/8075376

Vancouver

Abdelsalam M, Wahab AM, El Sayed Zaki M, Motawea M. MicroRNA-451 as an Early Predictor of Chronic Kidney Disease in Diabetic Nephropathy. International Journal of Nephrology. 2020;2020:1-7. doi:10.1155/2020/8075376

BibTeX
@article{Abdelsalam2020,
  author = {Abdelsalam, Mostafa and Wahab, A M and El Sayed Zaki, Maysaa and Motawea, Mohamad},
  title = {MicroRNA-451 as an Early Predictor of Chronic Kidney Disease in Diabetic Nephropathy},
  journal = {International Journal of Nephrology},
  year = {2020},
  volume = {2020},
  pages = {1--7},
  doi = {10.1155/2020/8075376}
}
Kostenlos starten →